4//SEC Filing
Goldstein Dan 4
Accession 0001127602-22-014976
CIK 0000313143other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:53 PM ET
Size
9.2 KB
Accession
0001127602-22-014976
Insider Transaction Report
Form 4
Goldstein Dan
Chief Accounting Officer
Transactions
- Sale
Common Stock
2022-05-16$56.10/sh−50$2,805→ 4,004 total - Award
Non-qualified Stock Option (Right to Buy)
2022-05-16+2,029→ 2,029 totalExercise: $57.60Exp: 2029-05-16→ Common Stock (2,029 underlying) - Award
Common Stock
2022-05-16+868→ 4,872 total
Footnotes (5)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This number includes unvested RSUs previously reported.
- [F3]The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F4]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F5]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001722327
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:53 PM ET
- Size
- 9.2 KB